All
What’s old is new: Microneedling
November 9th 2016Microneedling techniques are mimicking results often associated with laser treatment, according to Tina S. Alster, M.D., director of Washington Institute of Dermatologic Laser Surgery, Washington, DC, who presented “Will Microneedling Replace Lasers?” at the 2016 American Society for Dermatologic Surgery (ASDS) annual meeting in New Orleans.
Research looks at melanocyte role in tumor formation
November 8th 2016While melanocytes have strong mechanisms for repair, those in individuals with certain risk factors may carry impaired repair responses. Studies have begun to examine melanocytes in patients at risk for developing melanoma with the hope of developing strategies for preventing deadly tumors.
More evidence links psoriasis to depression
November 7th 2016A recent study provides more evidence that patients with psoriasis–even mild cases–face a higher risk of major depression, a finding that could lead dermatologists to alert patients with the condition and even screen them for mental health issues.
Study: Wearable patch may minimize peanut allergy
October 26th 2016A wearable skin patch (Viaskin, DBV Technologies) may help treat peanut allergy, specifically in children and young adults, according to one-year results of an ongoing trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the NIAID-funded Consortium of Food Allergy Research(CoFAR).
Cumulative dosing of isotretinoin should not follow strict range
October 24th 2016Cumulative dosing of isotretinoin has followed a reference range of 120 to 150 mg/kg, but there is an absence of strong evidence supporting this recommendation, pointing to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.
Novartis announces new Cosentyx data in psoriasis treatment, including long-term study
October 19th 2016Researchers presented new data on the use of the fully human IL-17A inhibitor Cosentyx (secukinumab, Novartis) in moderate-to-severe psoriasis, at the 25th European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria, September 28 through October 2, 2016.
Update on advanced basal cell carcinoma diagnosis and treatment
October 18th 2016Despite increased insight on skin cancer risk factors, the incidence continues to rise worldwide. This review article summarizes new treatment options available, which help to redefine and expand the diagnosis of advanced BCC and allow dermatologists to offer more effective therapy to a broader population.